Cell Therapy Media Market by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Co

Cell Therapy Media Market by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035

CELL THERAPY MEDIA MARKET: OVERVIEW

As per Roots Analysis, the global cell therapy media market is estimated to grow from USD 1.1 billion in the current year to USD 4.4 billion by 2035, at a CAGR of ~12% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Product

Culture Media, Kits

Cell Culture Reagents

Extracellular Matrices

Type of Cell Therapy

T-Cell Therapy

Stem Cell Therapy

Dendritic Cell Therapy

NK Cell Therapy

Scale of Operation

Clinical

Commercial

Type of End User

Industry

Non-Industry

Key Geographical Regions

North America

Europe

Asia-Pacific

Middle East and North Africa

Latin America

CELL THERAPY MEDIA MARKET: GROWTH AND TRENDS

Driven by numerous advancements and the proven success of FDA approved cell therapies for the treatment of oncological disorders, rare diseases, and chronic diseases, this therapeutic modality has garnered considerable attention of players engaged in the healthcare industry. It is worth highlighting that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. Additionally, over 35 cell and gene therapies have been commercialized, across various geographical locations. Notable examples of recently approved cell therapies include Breyanzi®, Carvykti™ and Abecma®.

In recent years, regulatory stringency has increased for the production of cell therapy. In order to address the regulatory challenges linked to the production of cell therapy consumables, over 90% of cell therapy developers choose to outsource culture media, kits, reagents and extracellular matrices to suppliers who possess the necessary expertise to deliver high-quality raw materials. At present, more than 80 players are offering more than 450 research and / or therapeutic grade raw materials. In addition, some companies claim to have GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells. As the landscape of cell therapy continues to evolve, we anticipate a surge in innovation and collaboration within the industry, paving the way for new therapeutic options that could transform patient care and expand the horizons of regenerative medicine.

CELL THERAPY MEDIA MARKET: KEY INSIGHTS

The report delves into the current state of the cell therapy media market and identifies potential growth opportunities within the industry. Some key findings from the report include:

1. Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes.

2. The market features the presence of over 80 firms across the globe; the majority of these stakeholders are emerging players based in North America.

3. A larger proportion of the kits available in the cell therapy domain comprises different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions.

4. Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml.

5. Predominantly, the cell therapy reagents are intended to be used at the discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation.

6. The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation.

7. In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios.

8. Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities.

9. We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings.

10. Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies.

11. Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process.

12. In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy consumables; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies.

13. A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy consumables market at an annualized rate of 12%.

CELL THERAPY MEDIA MARKET: KEY SEGMENTS

Extracellular Matrices is the Fastest Growing Segment in the Cell Therapy Media Market

Based on the type of product, the market is segmented into culture media, kits, cell culture reagents and extracellular matrices. It is worth highlighting that majority of the current cell therapy media market is captured by culture media.

T-Cell Therapy is Likely to Dominate the Cell Therapy Media Market During the Forecast Period

Based on the type of cell therapy, the market is segmented into T-Cell therapy, stem cell therapy, dendritic cell therapy and NK cell therapy. It is worth highlighting that the cell therapy consumables market for NK cell therapies is likely to grow at a relatively higher CAGR, during the forecast period. This can be attributed to the fact that currently, more than 75 NK cell therapy focused clinical studies are being evaluated for a myriad of disease indications. In the coming years, this number is anticipated to increase further, and this is likely to boost the market opportunity for such therapies.

By Scale of Operation, Commercial Scale is Likely to Dominate the Cell Therapy Media Market During the Forecast Period

Based on the scale of operation, the market is segmented into clinical and commercial scales. It is worth highlighting that the commercial scale cell therapy media market is likely to drive the market in the near future.

Industry Players Segment Accounts for the Largest Share of the Cell Therapy Media Market

Based on the type of end user, the market is segmented into industry and non-industry. It is worth highlighting that the cell therapy media market for industry players is likely to drive the market in the near future. This can be attributed to the fact that the industry players contribute significantly to the overall commercial market as majority of the approved therapies have been developed by such players.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Latin America is expected to grow at a higher CAGR.

Example Players in the Cell Therapy Media Market

BD Biosciences

Bio-Techne

CellGenix

Corning

Irvine Scientific (Acquired by FUJIFILM)

Lonza

Miltenyi Biotech

Sartorius

STEMCELL Technologies

Thermo Fisher Scientific

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

Vice President of Business Development - Cell Therapy, Akadeum Life Sciences

Chief Operating Officer, Cellular Engineering Technologies

Director R&D, Cell Culture and Immunology, HiMedia Laboratories

Assistant R&D Manager, Animal Cell Culture, HiMedia Laboratories

CELL THERAPY MEDIA MARKET: RESEARCH COVERAGE

The report features an in-depth analysis of the cell therapy media market, focusing on key market segments, including type of product, type of cell therapy, scale of operation, type of end user and key geographical regions.

A comprehensive evaluation of companies offering cell culture consumables and cell culture media, considering various parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of product (kits, media, reagents and extracellular matrices), number and location of consumable facilities, accreditations received, type of end-user (industry and non-industry), cell culture media compatibility (serum free media, xeno free media and both), type of cell therapy (T-cell therapies, stem cell therapies, NK cell therapies, dendritic cell therapies and others), type of function (cell proliferation, cell expansion, cell differentiation, cell activation, cell isolation, cell attachment), kit components (supplements / reagents, growth / induction medium, expansion medium, differentiation medium and others), type of ECM coating (laminin, fibronectin, vitronectin, basement membrane extract and others), type of formulation (powder, liquid, pre-coated cultureware), shelf life (6-12 months, 13-18 months, 19-24 months and 25-36 months), scale of operation (discovery, preclinical, clinical and commercial), application area (research use and therapeutic use), storage temperature (refrigerated, frozen, ultra-low and room temperature), as well as volume of media, reagents and extracellular matrices.

A comprehensive competitive analysis of companies operating in the cell culture consumable and cell culture media market, examining factors such as supplier strength, portfolio strength and number of products offered.

A detailed brand positioning analysis of prominent industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.

In-depth profiles of key industry players in cell therapy consumables and cell culture media market, focusing on company overviews, product portfolio, consumable facilities, recent developments and an informed future outlook.

An analysis of recent developments within the cell culture consumables and cell culture media market, since 2016, covering partnerships and collaborations, mergers and acquisitions, and expansion initiatives.

A detailed evaluation of over 250 cell therapy developers that are most likely to collaborate with cell culture consumables and cell culture media providers. This analysis considers various relevant parameters, including developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.

A proprietary Roots Analysis competitive pricing framework, which analyzes the competitive position of various companies engaged in cell culture consumables and cell culture media market, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices). In addition, it presents an equation devised to calculate the likely price of cell therapy consumables based upon their characteristics.

Informed estimates of the annual demand for cell culture consumables and cell culture media (in terms of volume of media required for total number of cells), based on scale of operation and key geographical regions.

A comprehensive analysis of emerging trends and future growth prospects in the cell culture consumables and media market. It includes details related to the significance of automation in cell therapy manufacturing processes and the benefits of single use technologies for the production of cell therapies.

KEY QUESTIONS ANSWERED IN THIS REPORT

What are the factors driving the cell therapy consumables market?

How many players are engaged in offering cell culture media for manufacturing cell therapies?

How many players are engaged in offering kits for manufacturing cell therapies?

How many media products are available in the market for culturing cell therapies?

What are the partnership and collaboration trends observed in the cell therapy consumables domain?

Which geographical segment captures the largest market share in the current cell therapy consumables market?

Which type of product contributes to the largest share of the cell therapy consumables market?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.

Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.

The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs

Complimentary Excel Data Packs for all Analytical Modules in the Report

10% Free Content Customization

Detailed Report Walkthrough Session with Research Team

Free Updated report if the report is 6-12 months old or older